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Abstract
The literature is clear that the diagnosis, treatment, and plan of care for hypertension in
adults should rely, at least in part, on ambulatory blood pressure. Using in-office blood pressures
alone risks inaccurate measurements and can result in inappropriate treatments. Many clinics,
however, do not adhere to this recommendation and will fall back on clinic readings which puts
the patient at risk of mismanaged hypertension and polypharmacy. This project was formulated
to identify the extent to which hypertensive patients were diagnosed and managed without the
use of home blood pressure monitoring in a small local community clinic. This project will also
explore and identify sources for low-to-no cost at-home monitors for patient use. The hope is that
this project will encourage a future project to initiate routine home blood pressure monitoring for
hypertensive patients at this clinic to improve adherence to evidence-based practice.
Keywords: white coat hypertension, ambulatory blood pressure, home blood pressure,
hypertension, outpatient clinic
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Identifying Opportunities for Implementing Home Blood Pressure Monitoring in Newly
Diagnosed or Worsening Hypertension at a Family Health Clinic
Hypertension is a relatively simple disease. Its diagnosis does not require expensive tests
or imaging and the treatments options include some of the cheapest drugs available. Its relative
simplicity, however, belies the complexity and severity the condition can have on the human
body.
Affecting close to half of the adult population in the United States, hypertension’s hold
on the country cannot be understated (Center for Disease Control, 2020). It is silent, insidious,
and deadly, and though relatively simple in its pathophysiology, mainly increased arterial
pressure in the blood vessels of the body, hypertension can be stubborn to treat. Aside from
being exceedingly common, chronic hypertension can have significant lasting effects on a
person’s health. Not only is hypertension the primary or contributory factor in the deaths of
nearly half a million Americans every year (Center for Disease Control, 2020), but it is also the
most important modifiable risk factor in premature deaths worldwide as reported by the World
Health Organization in 2009. In 2010 alone it was reported to have been a factor in 18% or 9.4
million deaths worldwide (Campbell et al., 2015). Chronically elevated blood pressure can have
system wide effects ranging from stroke, cardiovascular disease, renal disease, some forms of
dementia, and retinopathy, conditions that affect millions.
Historically, hypertension was not considered a disease until the early 1800’s, less than a
hundred years after blood pressure was first identified as a measurement of the body’s vital
function (Kotchen, 2011). Essential hypertension, the name for elevated blood pressure without a
primary cause, was coined in the early 20th century making the diagnosis fairly new in the
lexicon of human disease (Esunge, 1991). It took until the middle of the 1900’s before treatment
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was even considered for “mild” hypertension (blood pressures below 210/100 mmHg) (Moser,
2006) (Pickering, 1952). Around the same time diuretics were discovered, heralding a new era of
improved cardiovascular health. It is presumed that the 50% decrease in stroke and ischemic
heart disease between 1972 and 1994 was at least partially due to the subsequent treatment of
hypertension (Dustan, Roccella, & Garrison, 1996).
Today hypertension is diagnosed and treated far more liberally. Systolic blood pressure
readings routinely above 120mmHg are now considered elevated and a formal diagnosis of
hypertension is made when they are above 130mmHg, a far cry from the 200s range required in
the 20th century. Treatment typically starts slowly with lifestyle changes such as weight loss,
exercise, and reduced sodium intake. Medications such as diuretics, calcium channel blockers,
angiotensin II receptor blockers, and angiotensin converting enzyme inhibitors are often added
later if lifestyle changes are unable to make a significant dent in readings.
Simple to diagnose and usually simple to treat, hypertension has become a one of
the most frequently seen conditions in the primary care clinic and it is often easily managed by
most general clinicians. There is, however, always room for improvement. This project will
serve to highlight one clinic’s deviation from recommended practice and how it might be
encouraged to follow guidelines to better manage this common but potentially serious condition.
Purpose
Currently, a small adult general medicine clinic in Southern California provides
hypertension diagnoses and bases treatment plans on attended blood pressure measurements
taken at the clinic. The provider does not routinely rely on home measurements for the diagnosis
or treatment of hypertension. Most, if not all, patients are diagnosed and treated based on isolated
elevated measurements obtained in-office. This project was created with the purpose of
identifying just how extensive the use of in-office blood pressures is at this particular clinic for

10
hypertensive patients and whether this is a significant defect in following evidence-based
guidelines that would benefit from a change in practice. This project is a stepping-stone created
to identify an opportunity for a future project to encourage the practice of using home blood
pressure monitoring at this location. It did not serve to implement a change in practice, only to
establish the need for a practice change.
This original purpose of this project was to prove the existence of and better recognize
falsely elevated in-clinic blood pressure, also called White Coat Hypertension, and to create a
plan around managing the condition. In practice, however, finding enough patients who fit that
criteria as well as designing a treatment plan would have required time and dedication this
project could not muster. And so, the plan was revised and devised to essentially encourage
evidenced-based practice in the ambulatory clinic by highlighting an opportunity for change.
Evidence for Problem
A review of literature was completed using the following search engines: Cochrane, PubMed,
and CINAHL. Keywords utilized with each search engine were hypertension,
diagnosis/treatment/management of hypertension, ambulatory blood pressure, in-office blood
pressure, and White Coat Hypertension. This search yielded over 242 articles from the past 5
years from peer-reviewed publications. Articles were ranked based on the rigor of the study with
priority taken for meta-analyses. Policies and guidelines for large organizations and public health
centers nationally and internationally were also included in the research as sources of evidence.
Most major organizations for cardiovascular health including the American Heart
Association (AHA) and the American College of Cardiology (ACC) follow the “Guideline for
the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults”
created by the ACC/AHA task force in 2017. This guideline outlines the current recommended
practice for diagnosing hypertension which requires a resting systolic blood pressure average at
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or above 130mmHg from 2-3 measurements taken over 2-3 separate occasions while the patient
is at rest and on a chair. Measurements above 120mmHg are considered “elevated” but are not
quite high enough for a formal diagnosis. Once consistently above 130mmHg the diagnosis is
divided into two stages: stage I for average measurements between 130-140mmHg and stage II
for average measurements above 140mmHg.
The 2020 International Society of Hypertension Global Hypertension Practice Guidelines
offers another perspective on how providers diagnose and manage patients outside of the United
States. This guideline differs slightly from the American guideline by classifying hypertension as
systolic blood pressures equal or above 140mmHg or diastolic blood pressures equal or above
90mmHg, but like its American counterpart, it recommends averaging results over 2-3 separate
visits as opposed to separate occasions (Unger et al. 2020).
One key recommendation that all medical powerhouses agree on is that the diagnosis of
hypertension should rely more on multiple unattended or home blood pressure measurements
rather than on single, attended, infrequent measurements taken in-office. It is preferred to utilize
ambulatory or home measurements to confirm the diagnosis as it is often lower than in-clinic
measurements with an average of a 5-point decrease (Keely, 2020). It is even noted in the 2020
International Society of Hypertension Global Hypertension Practice Guidelines that blood
pressure cut-offs for the diagnosis of hypertension depend on the source of the results.
Ambulatory blood pressure readings have a threshold of diagnosis 5 points lower than that of
readings taken in the office (Unger, 2020). This difference can even be found in unattended
measurements (wherein the patient has their vitals taken during an office visit without the
presence of a staff member). The use of unattended, ambulatory blood pressure readings is vital
because it is more accurate and is more accurately tied with an increased risk of death and
cardiovascular heart disease and stroke compared to readings taken in the clinic (Whelton et al.,
2017). Not only does home blood pressure monitoring make a difference in diagnosis, it also has
been shown to improve adherence to treatment and thereby improving hypertension control rates
overall (Stergiou et al., 2014). It also important to note that treating patients who are diagnosed
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with hypertension based solely on elevated blood pressure in the clinic, also called White Coat
Hypertension, did not reduce the risk of cardiovascular events (Xiang, 2020). This highlights the
importance of identifying whether a patient has consistently elevated blood pressure that could
benefit from antihypertensives or whether they just have transient hypertension that may be
unaffected by medication.
Medicare has attempted to addresses the issue of false hypertension by covering the use
of a yearly “Ambulatory Blood Pressure Device”. This device is a small instrument worn on the
arm that will take blood pressure measurements at different intervals during a full 24- or 48-hour
period, creating a more accurate picture of a patient’s usual blood pressure on a given day. It can
be ordered by a provider for patients with suspected White Coat Hypertension or Masked
Hypertension, in which the blood pressure is normally higher than what is seen in the office
(AARP Medical Plans, n.d.). This device differs from the more commonly seen “home blood
pressure monitor” that can be purchased at any pharmacy over the counter and needs to be
applied and operated to take a single blood pressure measurement at a chosen moment. Though it
produces a more accurate and detailed log of a patient’s typical blood pressure, the Ambulatory
Blood Pressure Device, is cumbersome and inconvenient, most physicians and patients are
disinclined to use it. The over-the-counter option is preferred in most cases instead.
Framework
The decision to choose the 8A’s framework was originally chosen as it is a San Diego
native EBP model. Created in 2007 by Carolyn Brown EdD, RN and Laurie Ecoff PhD, RN for
the San Diego Evidence-Based Practice Consortium, the model was adapted from an earlier EBP
model formulated by Mary Ann Rossworm and June Larrabee (Brown & Ecoff, 2011). This
framework was built in order to better formulate a streamlined process in which to establish
evidence-based change in practice.
The 8A’s EBP model begins by identifying a “Catalyst” which is the original reason
behind the project and is followed by “Assessing” which, as the name implies, is the process of
investigating the extent of the problem and how much of a “problem” it is. The model continues
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with “Asking” in which the PICOT (Population, Intervention, Comparison, Timeline) question is
formulated then “Acquiring” and “Appraising” which involves acquiring the evidence that
supports the change and appraising the quality of the research and evidence found. Finally, the
evidence is implemented or “applied” in the “Application” stage and the project truly gets
underway. Once implemented and the timeline is reached, the project outcomes are “Analyzed”
at which point the project is at the final stage: “Advancing and Adopting” wherein the results are
published and disseminated to spread change outside the confines of the original project.
It was really the “Assessing” stage that this project was developed for. Its purpose was
not to create a practice change but rather to identify the need for one.
Figure 1
San Diego’s 8A’s Evidence-Based Practice Model

Note. This figure lists the 8A’s stages to follow in order to implement an EBP change.
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Project Plan Process
As it was discovered that this clinic does not routinely utilize the recommendations of
home blood pressure monitoring it was decided to center this project around examining the true
extent of hypertension diagnosed at the clinic to determine if this change in practice
recommendations was likely to have a significant effect on a large percentage of its patient
population. The project also served to identify which patients diagnosed with hypertension could
qualify for a covered ambulatory monitoring device and whether this is a significant percentage
of the patient population seen at this clinic.
Patients whose blood pressure when taken in the office was above 130mmHg systolic
were included in the project and their demographics were recorded including their age, biological
sex, stated race or ethnicity, previous blood pressure readings, history of hypertension or
diabetes, and whether they were currently on blood pressure medication. Lastly, their insurance
information was also recorded to establish whether they would be entitled to free home
monitoring.
Assessment of Findings
Out of 75 patients whose records were examined, 50 presented with an elevated blood
pressure based on their blood pressure readings at the time of their visit. Those 50 patients were
included in the project and their data was subsequently collected. The information was extracted
from visits during the last two weeks of November where approximately 10 patients were seen
per day except for Wednesdays which had 5 patients for a rough total of 220 patients seen over
two weeks. The overwhelming majority of patients in any given day had blood pressure readings
above SBP 130, in fact typically only 1-3 patients per day had a normal blood pressure reading.
Save for a handful of patients who had taken matters into their own hands, most also did not
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regularly check their blood pressure at home so a true baseline was not established. None of the
patients had been offered to use a home blood pressure monitoring system or an ambulatory
blood pressure device to more accurately diagnosed and rate their hypertension even though
every Medicare patient seen qualified for one of these devices.
Of the 50 patients identified, over half (52%) presented with a reading above 140mmHg
and 10% had systolic blood pressures exceeding 180mmgHg which qualified them for a
diagnosis of hypertension based on that single reading alone (Whelton et al., 2017). Many of the
patients (40%) were at or above the age of 65, when Medicare coverage may potentially apply.
Ages ranged from 21 - 92 years and the group was divided pretty evenly amongst gender lines
(24 women and 26 men). Half were of Hispanic or Latino ethnicity, 19 were Caucasian, 4 were
of an unstated race, and 2 were Asian.
Of the patients seen, 19 had Medicare or a Medicare Replacement/Advantage plan which
would cover the yearly ambulatory device (AARP Medical Plans, n.d.) and 11 had Medicaid or
Medicaid Replacement/Advantage which covers a home device but only for malignant
hypertension or end-stage renal disease (California Health and Wellness, n.d.).
Of the 50 patients seen with an elevated in-office blood pressure, 32 had a history of
hypertension, 2 of which were not being treated with medication, 3 did not have a history of
diagnosed hypertension but had been prescribed anti-hypertensives. 17 had a comorbidity of
diabetes mellitus as well, while 5 had diabetes but no history hypertension, and 12 had no history
of hypertension or diabetes.
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Figure 2
Blood Pressure Stages

Blood Pressure Stages
Stage I
10%

Stage II

38%
52%

Stage III

Note. The division of blood pressure stages based on the patient’s initial reading.
Figure 3
Age Range
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Note. The range of ages for the 50 patients included in the project.
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Figure 4
Coverage Breakdown

Coverage
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Note. Number of patients in each coverage type.
Figure 5
Medical History
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Note. Patients divided by medical history.
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Cost/Benefit Analysis for Sustainability of Project:
The cost of hypertension cannot be ignored, both as a cost to the individual with the
diagnosis and to the country at large. The increase in annual healthcare costs for patients with
hypertension is significant at $2,000 and the costs for hypertension as a disease in the United
States is $131 billion (Kirkland, 2018).
By implementing this project patients may save up to $2,000 annually. For every dollar
spent $200 will be saved for the patient. CBA= (benefits) $2,000/(cost) $100= $200, making the
return of investment is 1,900%. ROI= {($2,000-$100)/$100}x100=1,900%.
Table 1
Cost/Benefit Analysis
Costs – Utilizing home blood pressure

Costs – Continuing with in-office blood

monitors

pressure readings alone

Financial

Non-Financial

-$0-100 per unit per

-Risk of

Financial
-Potential increased

patient depending on inaccuracy of

cost to patients to

insurance coverage

home monitors

treat hypertension

-No added cost to

-Increased

unnecessarily

the clinic

responsibility for

Non-Financial
-Risking overdiagnosing and
treating of
hypertension

patients
Benefits
Financial

Non-Financial

-Potential saving up to $2,000 annually

-Decrease in polypharmacy and

per patient who can avoid a diagnosed of

unnecessary treatment for patients

hypertension
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Implications for Practice
Implementing this project will require buy-in from the clinic staff and from the patients
themselves. It will change the entire process of diagnosing and treating hypertension that is in
place at the clinic now. This change can only be successful if the participants give it their best
effort. It will also require more maintenance and surveillance to assure the accuracy of each
induvial home monitor. As with some other practices, such as more specialized cardiology
clinics, this office should implement the use of manual blood pressure devices in order to prevent
technological errors or variances. This practice however requires training of staff and runs the
risk of variances in readings due to human error.
Conclusions
The results of this project will hopefully show that there is a great opportunity for
implementing home blood pressure monitoring to establish a more accurate picture of a patient’s
condition and better identify tailored treatment options and care plans. This will also integrate
the patient into their own healthcare and make them a more active participant in their health.
It should be noted that this project is limited to the office in which it was conducted and
future projects using this data should only be attempted at this particular office.
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